Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 54 | 2 | 2 | 0 | €458.45 | €440.93 | -3.822% |
| Fresenius SE & Co. KGaA | 3 | 0 | 0 | 0 | €31.92 | - | - |
| Merck KGaA | 3 | 2 | 0 | 0 | €159.10 | €146.00 | -8.234% |
| Sartorius AG VZO | 5 | 0 | 1 | 0 | €244.80 | - | - |
| QIAGEN NV | 11 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.80 | €65.00 | -4.130% |
| Gerresheimer AG | 4 | 0 | 0 | 0 | €94.85 | - | - |
| Drägerwerk AG & Co. KGaA VZO | 4 | 0 | 0 | 0 | €48.80 | €60.00 | 22.951% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 6 | 0 | 0 | 0 | €43.52 | €95.00 | 118.290% |
| Fresenius Medical Care AG & Co KGaA ST | 3 | 0 | 0 | 0 | €37.30 | €50.00 | 34.048% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €146.00 | €165.00 | 13.014% |
| Sanofi S.A. | 3 | 0 | 0 | 0 | €96.85 | €99.50 | 2.736% |
| Novo Nordisk A/S | 5 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Pfizer Inc. | 29 | 4 | 0 | 0 | €28.18 | €41.29 | 46.539% |
| Johnson & Johnson | 39 | 1 | 2 | 0 | €147.62 | €195.31 | 32.303% |
| UnitedHealth Group Inc. | 42 | 2 | 3 | 0 | €527.40 | €547.55 | 3.820% |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | €116.80 | €124.97 | 6.998% |
| Align Technology | 21 | 2 | 4 | 0 | €207.20 | €315.49 | 52.262% |
| Biogen Inc. | 52 | 1 | 0 | 0 | €198.10 | €292.88 | 47.843% |
| Amgen Inc. | 25 | 0 | 0 | 0 | €309.35 | €304.65 | -1.520% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 2 | 0 | €999.00 | €1,034.6 | 3.567% |
| Stratec SE | 2 | 0 | 0 | 0 | €41.30 | - | - |